| 000 | 01224 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250512023015.0 | ||
| 264 | 0 | _c19860318 | |
| 008 | 198603s 0 0 eng d | ||
| 022 | _a0278-5846 | ||
| 024 | 7 |
_a10.1016/0278-5846(85)90011-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNair, N P | |
| 245 | 0 | 0 |
_aCholecystokinin peptides, dopamine and schizophrenia--a review. _h[electronic resource] |
| 260 |
_bProgress in neuro-psychopharmacology & biological psychiatry _c1985 |
||
| 300 |
_a515-24 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntipsychotic Agents _xpharmacology |
| 650 | 0 | 4 |
_aCeruletide _xtherapeutic use |
| 650 | 0 | 4 |
_aCholecystokinin _xmetabolism |
| 650 | 0 | 4 |
_aDopamine _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeurotransmitter Agents _xcerebrospinal fluid |
| 650 | 0 | 4 |
_aReceptors, Dopamine _xdrug effects |
| 650 | 0 | 4 |
_aSchizophrenia _xmetabolism |
| 650 | 0 | 4 |
_aSincalide _xtherapeutic use |
| 700 | 1 | _aLal, S | |
| 700 | 1 | _aBloom, D M | |
| 773 | 0 |
_tProgress in neuro-psychopharmacology & biological psychiatry _gvol. 9 _gno. 5-6 _gp. 515-24 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0278-5846(85)90011-9 _zAvailable from publisher's website |
| 999 |
_c2874337 _d2874337 |
||